过度表达β-TrCP通过耗尽BRCA1来增强西斯普拉丁的敏感性
Rocío Jiménez-Guerrero1, Alejandro Belmonte-Fernández2, Mónica González-Moreno1
1Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain.
Molecular oncology
|July 28, 2025
概括
调查E3泛基因酶SCF (β-TrCP) 在西斯普拉丁耐药性中的作用,揭示了它对DNA修复蛋白 BRCA1 和 CtIP 的影响. 调节β-TrCP会影响瘤细胞对化疗的敏感性.
科学领域:
- 分子瘤学分子瘤学
- 癌症化疗 癌症化疗
- 乌比基酸联酶的功能
背景情况:
- 西斯是一种广泛使用的化疗剂,但获得的瘤细胞耐药性显著限制了其疗效.
- 了解耐药机制对于改善患者的治疗结果和克服治疗失败至关重要.
- E3泛基因酶SCF (β-TrCP) 调节蛋白质的稳定性,并已涉及到各种细胞过程.
研究的目的:
- 为了研究SCF (β-TrCP) 在癌细胞中介于西斯普拉丁耐药性的作用.
- 分析SCF (β-TrCP) 对BRCA1和CTIP稳定性的影响,这是DNA修复中的关键参与者.
- 阐明SCF (β-TrCP) 影响西斯普拉丁敏感性和DNA损伤反应的机制.
主要方法:
- 利用各种瘤细胞系研究西斯普拉丁耐药性.
- 操纵β-TrCP表达,使用野生类型和主导阴性突变的过度表达,以及siRNA介导的淘汰.
- 评估了DNA损伤,细胞亡,蛋白质与蛋白质相互作用 (BRCA1,CtIP,β-TrCP) 和蛋白质降解途径 (溶酶体和蛋白质体).
主要成果:
- 野生类型β-TrCP的过度表达增强了DNA损伤和西斯胺诱导的亡.
- 抑制β-TrCP (主导阴性突变或siRNA) 减少了DNA损伤,并赋予了对西斯的耐药性.
- β-TrCP与BRCA1和CtIP直接相互作用,其调节改变了它们的蛋白质水平;通过lysosomal和proteasomal途径发生β-TrCP介导的BRCA1降解.
结论:
- SCF (β-TrCP) 通过控制DNA修复蛋白 BRCA1 和 CtIP 的稳定性,在调节西斯普拉丁敏感性方面发挥着关键作用.
- 有效的β-TrCP介导的BRCA1降解对于有效的DNA损伤修复至关重要,其失败导致西斯普拉丁耐药性.
- 向β-TrCP或其与BRCA1的相互作用可能是克服癌症治疗中西斯普拉丁耐药性的新策略.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K